1. Modulations of ferroptosis in lung cancer therapy
   Robert Walters et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
2. IFNγ enhances ferroptosis by increasing JAK‑STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma
   Xinbo Yu et al, 2022, Oncol Rep CrossRef
3. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
   Jiaqin He et al, 2022, Biochem Pharmacol CrossRef
4. The role of microRNAs in ferroptosis
   Liqing Guo et al, 2022, Front. Mol. Biosci. CrossRef
5. Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells
   Erva Ozkan et al, 2022, Life Sciences CrossRef
6. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective
   Jiaming Liang et al, 2023, Cell Death Discov. CrossRef
7. Targeting ferroptosis in gastric cancer: Strategies and opportunities
   Jiahan Le et al, 2023, Immunological Reviews CrossRef
8. Cucurbitacin B and erastin co-treatment synergistically induced ferroptosis in breast cancer cells via altered iron-regulating proteins and lipid peroxidation
   Filiz Bakar-Ates et al, 2023, Toxicology in Vitro CrossRef
9. Role of SLC7A11/xCT in Ovarian Cancer
   Sonia Fantone et al, 2024, IJMS CrossRef
10. Ascorbic acid induces ferroptosis via STAT3/GPX4 signaling in oropharyngeal cancer
    Kaiyuan Wu et al, 2024, Free Radical Research CrossRef
11. Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy
    Debiao Xiang et al, 2024, IJN CrossRef
12. High expression of AlkB homolog 5 suppresses the progression of non‐small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11
    Zhangzhou Huang et al, 2024, Environmental Toxicology CrossRef